Payment Breakdown by Category
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Food and Beverage | $3,330 | 108 | 85.2% |
| Long term medical supply or device loan | $560.00 | 2 | 14.3% |
| Education | $17.84 | 1 | 0.5% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Ocular Therapeutix, Inc. | $560.00 | 2 | $0 (2024) |
| Johnson & Johnson Surgical Vision, Inc. | $544.13 | 10 | $0 (2023) |
| Allergan, Inc. | $520.72 | 12 | $0 (2022) |
| ABBVIE INC. | $338.43 | 12 | $0 (2024) |
| Alcon Vision LLC | $316.89 | 16 | $0 (2024) |
| Glaukos Corporation | $258.19 | 6 | $0 (2024) |
| Bausch & Lomb Americas Inc. | $195.49 | 10 | $0 (2024) |
| Novartis Pharmaceuticals Corporation | $165.97 | 8 | $0 (2023) |
| Omeros Corporation | $161.51 | 5 | $0 (2017) |
| Alimera Sciences, Inc. | $127.49 | 1 | $0 (2019) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $1,207 | 24 | Ocular Therapeutix, Inc. ($560.00) |
| 2023 | $409.28 | 15 | AbbVie Inc. ($203.65) |
| 2022 | $258.39 | 12 | Alcon Vision LLC ($97.33) |
| 2021 | $420.32 | 15 | Ivantis, Inc ($99.24) |
| 2020 | $347.86 | 14 | Allergan, Inc. ($171.70) |
| 2019 | $428.24 | 6 | Allergan Inc. ($249.82) |
| 2018 | $170.92 | 6 | Johnson & Johnson Surgical Vision, Inc. ($110.51) |
| 2017 | $665.21 | 19 | Johnson & Johnson Surgical Vision, Inc. ($350.66) |
All Payment Transactions
111 individual payment records from CMS Open Payments — Page 1 of 5
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 10/08/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug), Ryzumvi | Food and Beverage | In-kind items and services | $17.24 | General |
| Category: Dry eyes | ||||||
| 10/08/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $13.38 | General |
| Category: Ophthalmology | ||||||
| 10/03/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $21.24 | General |
| Category: EYE CARE | ||||||
| 09/06/2024 | Amgen Inc. | TEPEZZA (Biological) | Food and Beverage | In-kind items and services | $19.38 | General |
| Category: Inflammation/Rare Disease | ||||||
| 08/12/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $31.37 | General |
| Category: Ophthalmology | ||||||
| 08/01/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $20.95 | General |
| Category: Ophthalmology | ||||||
| 07/16/2024 | Oyster Point Pharma, Inc. | TYRVAYA (Drug) | Food and Beverage | In-kind items and services | $19.06 | General |
| Category: Dry eyes | ||||||
| 07/12/2024 | ABBVIE INC. | LUMIGAN (Drug) | Food and Beverage | In-kind items and services | $20.72 | General |
| Category: EYE CARE | ||||||
| 07/11/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $38.55 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 06/27/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $17.54 | General |
| Category: Ophthalmology | ||||||
| 06/11/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $26.35 | General |
| Category: EYE CARE | ||||||
| 06/04/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $20.56 | General |
| Category: Ophthalmology | ||||||
| 05/08/2024 | Alcon Vision LLC | Clareon (Device) | Food and Beverage | In-kind items and services | $21.68 | General |
| Category: Ophthalmology | ||||||
| 04/11/2024 | Alcon Vision LLC | Rocklatan (Drug) | Food and Beverage | In-kind items and services | $22.62 | General |
| Category: Ophthalmology | ||||||
| 04/01/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $23.07 | General |
| Category: Ophthalmology | ||||||
| 03/26/2024 | Harrow Eye, LLC | VEVYE (Drug) | Food and Beverage | In-kind items and services | $15.48 | General |
| Category: OPTOMETRY | ||||||
| 03/22/2024 | Glaukos Corporation | iStent Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $38.12 | General |
| Category: Glaucoma | ||||||
| 03/12/2024 | Glaukos Corporation | iStent Trabecular Micro-Bypass System Model iS3 (Device) | Food and Beverage | Cash or cash equivalent | $160.44 | General |
| Category: Glaucoma | ||||||
| 02/27/2024 | ABBVIE INC. | DURYSTA (Drug) | Food and Beverage | In-kind items and services | $24.51 | General |
| Category: EYE CARE | ||||||
| 02/21/2024 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $20.44 | General |
| Category: Ophthalmology | ||||||
| 02/08/2024 | Tarsus Pharmaceuticals, Inc. | XDEMVY (Drug) | Food and Beverage | In-kind items and services | $35.92 | General |
| Category: DEMODEX BLEPHARITIS | ||||||
| 02/06/2024 | Bausch & Lomb Americas Inc. | XIIDRA (Drug) | Food and Beverage | In-kind items and services | $18.71 | General |
| Category: Ophthalmology | ||||||
| 01/17/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Long term medical supply or device loan | In-kind items and services | $300.00 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 01/17/2024 | Ocular Therapeutix, Inc. | DEXTENZA (Drug) | Long term medical supply or device loan | In-kind items and services | $260.00 | General |
| Category: Corticosteroid intracanalicular insert | ||||||
| 12/14/2023 | Bausch & Lomb Americas Inc. | MIEBO (Drug) | Food and Beverage | In-kind items and services | $24.54 | General |
| Category: Ophthalmology | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 20 | 3,323 | 3,881 | $1.2M | $340,696 |
| 2022 | 21 | 3,488 | 4,172 | $1.5M | $358,948 |
| 2021 | 17 | 3,274 | 4,088 | $1.2M | $363,867 |
| 2020 | 18 | 2,923 | 3,517 | $463,183 | $314,479 |
All Medicare Procedures & Services
79 procedure records from CMS Medicare Utilization — Page 1 of 4
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 92014 | Established patient complete exam of visual system | Office | 2023 | 1,654 | 1,902 | $602,687 | $158,048 | 26.2% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2023 | 103 | 151 | $192,683 | $64,032 | 33.2% |
| 92012 | Established patient problem focused exam of visual system | Office | 2023 | 267 | 351 | $79,146 | $20,471 | 25.9% |
| 92004 | New patient complete exam of visual system | Office | 2023 | 150 | 150 | $56,303 | $13,504 | 24.0% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2023 | 47 | 56 | $47,163 | $13,366 | 28.3% |
| 99214 | Established patient office or other outpatient visit, 30-39 minutes | Office | 2023 | 111 | 131 | $42,048 | $12,950 | 30.8% |
| 65820 | Incision to improve eye fluid flow | Facility | 2023 | 14 | 18 | $28,949 | $11,544 | 39.9% |
| 92134 | Imaging of retina | Office | 2023 | 227 | 254 | $25,949 | $7,010 | 27.0% |
| 99213 | Established patient office or other outpatient visit, 20-29 minutes | Office | 2023 | 80 | 92 | $20,882 | $6,380 | 30.6% |
| 92133 | Imaging of optic nerve | Office | 2023 | 227 | 241 | $22,481 | $6,230 | 27.7% |
| 92136 | Measurement of corneal curvature and depth of eye | Office | 2023 | 121 | 177 | $19,568 | $6,190 | 31.6% |
| 66991 | Extracapsular removal of cataract with insertion of artificial lens and insertion of drainage device in front chamber of eye | Facility | 2023 | 14 | 17 | $23,415 | $4,467 | 19.1% |
| 68761 | Closure of tear duct opening using plug | Office | 2023 | 26 | 41 | $43,153 | $3,956 | 9.2% |
| 67840 | Removal of growth of eyelid | Office | 2023 | 15 | 16 | $12,803 | $3,505 | 27.4% |
| 99212 | Established patient office or other outpatient visit, 10-19 minutes | Office | 2023 | 72 | 77 | $10,953 | $3,406 | 31.1% |
| 92083 | Exam of visual field with extended testing | Office | 2023 | 61 | 65 | $10,285 | $3,121 | 30.3% |
| 92020 | Exam of the internal drainage system of eye | Office | 2023 | 76 | 81 | $5,615 | $1,479 | 26.3% |
| 92250 | Photography of the retina | Office | 2023 | 25 | 25 | $4,277 | $689.77 | 16.1% |
| 67820 | Removal of eyelashes using forceps | Office | 2023 | 12 | 15 | $795.41 | $215.88 | 27.1% |
| 76514 | Ultrasound scan of cornea to determine thickness | Office | 2023 | 21 | 21 | $601.30 | $131.40 | 21.9% |
| 92014 | Established patient complete exam of visual system | Office | 2022 | 1,627 | 1,851 | $592,461 | $152,691 | 25.8% |
| 66984 | Removal of cataract with insertion of prosthetic lens | Facility | 2022 | 120 | 174 | $293,696 | $73,416 | 25.0% |
| 92012 | Established patient problem focused exam of visual system | Office | 2022 | 432 | 610 | $137,891 | $37,335 | 27.1% |
| 92004 | New patient complete exam of visual system | Office | 2022 | 192 | 192 | $72,758 | $18,006 | 24.7% |
| 66821 | Removal of recurring cataract in lens capsule using a laser | Facility | 2022 | 50 | 60 | $64,764 | $14,355 | 22.2% |
About Dr. John Roach, MD
Dr. John Roach, MD is a Ophthalmology healthcare provider based in Atlanta, Georgia. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 04/14/2006. The National Provider Identifier (NPI) number assigned to this provider is 1518921766.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. John Roach, MD has received a total of $3,908 in payments from pharmaceutical and medical device companies, with $1,207 received in 2024. These payments were reported across 111 transactions from 23 companies. The most common payment nature is "Food and Beverage" ($3,330).
As a Medicare-enrolled provider, Roach has provided services to 13,008 Medicare beneficiaries, totaling 15,658 services with total Medicare billing of $1.4M. Data is available for 4 years (2020–2023), covering 79 distinct procedure/service records.
Practice Information
- Specialty Ophthalmology
- Location Atlanta, GA
- Active Since 04/14/2006
- Last Updated 03/19/2019
- Taxonomy Code 207W00000X
- Entity Type Individual
- NPI Number 1518921766
Products in Payments
- DEXTENZA (Drug) $560.00
- DURYSTA (Drug) $381.86
- Tecnis 1-piece IOL (Device) $358.73
- LUMIGAN (Drug) $320.65
- XIIDRA (Drug) $274.78
- iStent Trabecular Micro-Bypass System Model iS3 (Device) $198.56
- Clareon (Device) $156.66
- Iluvien (Drug) $127.49
- OMIDRIA (Drug) $125.00
- MIEBO (Drug) $119.83
- Catalys Laser System (Device) $102.44
- Hydrus Microstent (Device) $99.24
- TYRVAYA (Drug) $98.97
- LUMERA 700 (Device) $87.93
- XDEMVY (Drug) $74.47
- VYZULTA (Drug) $73.44
- PROLENSA (Drug) $68.17
- Rocklatan (Drug) $53.99
- Luxor (Device) $46.72
- Omidria (Drug) $36.51
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Ophthalmology Doctors in Atlanta
Lawrence Woodard, M.d, M.D
Ophthalmology — Payments: $546,343
Arkadiy Yadgarov
Ophthalmology — Payments: $537,190
William Lee, Md, MD
Ophthalmology — Payments: $496,418
Stephanie Vanderveldt, Md, MD
Ophthalmology — Payments: $488,410
Dr. Gagan Sawhney, Md, MD
Ophthalmology — Payments: $419,278
Dr. Margaret Wong Gribble, Md, MD
Ophthalmology — Payments: $375,575